Notable Analyst Upgrades and Downgrades for Week of July 15, 2019

Upgrades:

Bank of America upgraded shares of Deere & Company (NYSE:DE) from a neutral rating to a buy rating in a report published on Monday morning, 24/7 WallStreet reports.

Several other analysts have also issued reports on DE. Macquarie set a $132.00 price target on shares of Deere & Company and gave the stock a hold rating in a research report on Monday, May 20th. Robert W. Baird raised shares of Deere & Company from a neutral rating to an outperform rating and upped their price target for the stock from $129.00 to $175.00 in a research report on Sunday, June 16th. Jefferies Financial Group raised shares of AGCO from a hold rating to a buy rating and upped their price target for the stock from $70.00 to $90.00 in a research report on Monday, June 24th. Wells Fargo & Co reissued a buy rating and issued a $85.00 price objective on shares of Carvana in a research report on Monday, July 1st. Finally, Morgan Stanley reissued a hold rating on shares of PG&E in a research report on Friday, June 21st. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus price target of $167.78. Read more …

Gilead Sciences (NASDAQ:GILD) was upgraded by equities research analysts at Wells Fargo & Co from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Monday, Marketbeat reports. The brokerage presently has a $88.00 target price on the biopharmaceutical company’s stock, up from their previous target price of $68.00. Wells Fargo & Co‘s price objective suggests a potential upside of 31.46% from the company’s current price.

Other equities analysts have also recently issued reports about the stock. Oppenheimer set a $85.00 target price on shares of Gilead Sciences and gave the company a “buy” rating in a research note on Friday, July 12th. Evercore ISI reaffirmed a “buy” rating on shares of Gilead Sciences in a research note on Friday, May 17th. Raymond James set a $60.00 target price on shares of Banner and gave the company a “buy” rating in a research note on Friday, May 3rd. Needham & Company LLC cut shares of Acquity Group from a “buy” rating to a “hold” rating in a research note on Monday, May 6th. Finally, JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Gilead Sciences in a research note on Tuesday, July 2nd. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and sixteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $80.54. Read more …

Edward Jones upgraded shares of General Mills (NYSE:GIS) from a hold rating to a buy rating in a research note published on Monday morning, The Fly reports.

A number of other brokerages also recently commented on GIS. Bank of America set a $120.00 price objective on Walmart and gave the company a buy rating in a research report on Friday, May 17th. JPMorgan Chase & Co. lowered VESTAS WIND SYS/ADR from a neutral rating to an underweight rating in a report on Thursday, March 21st. Wells Fargo & Co restated a hold rating and issued a $160.00 target price on shares of Willis Towers Watson in a report on Friday, March 22nd. Guggenheim increased their target price on General Mills from $58.00 to $65.00 and gave the company a buy rating in a report on Wednesday, July 10th. Finally, Piper Jaffray Companies increased their target price on General Mills from $50.00 to $56.00 and gave the company a neutral rating in a report on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating, five have issued a buy rating and two have given a strong buy rating to the stock. General Mills has a consensus rating of Hold and an average price target of $52.66. Read more …

ConocoPhillips (NYSE:COP) was upgraded by stock analysts at Bank of America from a “neutral” rating to a “buy” rating in a research report issued on Wednesday, The Fly reports.

A number of other equities analysts have also recently issued reports on the stock. Morgan Stanley set a $207.00 price target on shares of Alibaba Group and gave the stock a “buy” rating in a research note on Friday, July 12th. Credit Suisse Group reiterated an “outperform” rating and issued a GBX 2,012 ($26.29) price target on shares of Aston Martin Lagonda Global in a research note on Wednesday, May 1st. Zacks Investment Research upgraded shares of General Moly from a “sell” rating to a “hold” rating in a research note on Thursday, July 11th. Mizuho began coverage on shares of Avrobio in a research note on Wednesday, June 26th. They issued a “buy” rating and a $28.00 price target on the stock. Finally, ValuEngine upgraded shares of Zogenix from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 27th. Five equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $77.07. Read more …

Week's Most Significant Insider Trades: Week of September 3, 2018

Disposals:

Ventas, Inc. (NYSE:VTR) EVP T Richard Riney sold 13,708 shares of the stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $60.00, for a total value of $822,480.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. NYSE:VTR opened at $60.12 on Friday. The company has a quick ratio of 0.56, a current ratio of 0.56 and a debt-to-equity ratio of 0.97. The stock has a market cap of $21.34 billion, a P/E ratio of 14.45, a PEG ratio of 3.91 and a beta of 0.12. Ventas, Inc. has a 52-week low of $46.55 and a 52-week high of $69.92. Read more …

Autoliv Inc. (NYSE:ALV) Director Jan Carlson sold 42,589 shares of the business’s stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $89.53, for a total transaction of $3,812,993.17. Following the completion of the transaction, the director now directly owns 53,579 shares in the company, valued at $4,796,927.87. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Shares of ALV opened at $86.55 on Thursday. Autoliv Inc. has a twelve month low of $77.63 and a twelve month high of $115.37. The stock has a market cap of $7.76 billion, a PE ratio of 13.15, a P/E/G ratio of 0.67 and a beta of 1.25. The company has a current ratio of 1.23, a quick ratio of 0.97 and a debt-to-equity ratio of 0.84. Read more …

Franklin Resources, Inc. (NYSE:BEN) EVP Craig Steven Tyle sold 11,165 shares of the company’s stock in a transaction that occurred on Tuesday, September 4th. The stock was sold at an average price of $31.35, for a total value of $350,022.75. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Shares of BEN stock opened at $30.26 on Friday. Franklin Resources, Inc. has a 12 month low of $30.14 and a 12 month high of $45.96. The company has a market cap of $16.56 billion, a PE ratio of 9.91, a price-to-earnings-growth ratio of 1.63 and a beta of 1.52. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.37 and a quick ratio of 3.37. Read more …

Best Buy Co Inc (NYSE:BBY) insider Asheesh Saksena sold 26,309 shares of Best Buy stock in a transaction dated Wednesday, September 5th. The shares were sold at an average price of $80.07, for a total value of $2,106,561.63. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Asheesh Saksena also recently made the following trade(s):

On Thursday, June 14th, Asheesh Saksena sold 18,570 shares of Best Buy stock. The shares were sold at an average price of $73.69, for a total value of $1,368,423.30.

Week's Most Significant Insider Trades: March 19 - 23, 2018

Disposals:

Amgen, Inc. (NASDAQ:AMGN) EVP Sean E. Harper sold 1,525 shares of Amgen stock in a transaction dated Friday, March 16th. The stock was sold at an average price of $189.75, for a total value of $289,368.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Sean E. Harper also recently made the following trade(s):

-On Wednesday, February 14th, Sean E. Harper sold 1,525 shares of Amgen stock. The stock was sold at an average price of $174.18, for a total value of $265,624.50.

-On Tuesday, January 16th, Sean E. Harper sold 1,525 shares of Amgen stock. The stock was sold at an average price of $185.62, for a total value of $283,070.50.

Amgen stock traded down $5.69 on Monday, reaching $182.55. The company had a trading volume of 3,955,058 shares, compared to its average volume of 5,457,186. Amgen, Inc. has a 12-month low of $152.16 and a 12-month high of $201.23. The firm has a market capitalization of $135,638.63, a PE ratio of 71.03, a PEG ratio of 2.31 and a beta of 1.37. The company has a quick ratio of 5.17, a current ratio of 5.49 and a debt-to-equity ratio of 1.35. Readmore …

UnitedHealth Group Inc (NYSE:UNH) insider Larry C. Renfro sold 22,184 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total value of $5,078,804.96. Following the sale, the insider now directly owns 173,229 shares in the company, valued at $39,659,047.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Read more …

UnitedHealth Group Inc (NYSE:UNH) CEO Steven H. Nelson sold 14,233 shares of the firm’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $230.22, for a total transaction of $3,276,721.26. Following the completion of the transaction, the chief executive officer now directly owns 18,219 shares of the company’s stock, valued at approximately $4,194,378.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Shares of UNH stock opened at $226.78 on Wednesday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market cap of $220,491.67, a PE ratio of 21.17, a PEG ratio of 1.33 and a beta of 0.74. UnitedHealth Group Inc has a 12 month low of $162.74 and a 12 month high of $250.79. Read more …

NextEra Energy Inc (NYSE:NEE) Director James L. Robo sold 18,000 shares of the business’s stock in a transaction on Monday, March 19th. The stock was sold at an average price of $160.89, for a total transaction of $2,896,020.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Shares of NEE stock opened at $160.42 on Wednesday. NextEra Energy Inc has a one year low of $127.09 and a one year high of $161.69. The company has a current ratio of 0.64, a quick ratio of 0.52 and a debt-to-equity ratio of 1.07. The stock has a market cap of $75,294.08, a price-to-earnings ratio of 23.83, a price-to-earnings-growth ratio of 2.63 and a beta of 0.32. Read more …

Nucor Co. (NYSE:NUE) EVP Raymond S. Napolitan, Jr. sold 8,000 shares of the business’s stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $65.11, for a total transaction of $520,880.00. Following the transaction, the executive vice president now owns 78,381 shares in the company, valued at $5,103,386.91. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Shares of NUE stock traded up $1.02 on Wednesday, reaching $65.22. 1,468,134 shares of the company were exchanged, compared to its average volume of 2,996,258. Nucor Co. has a twelve month low of $51.67 and a twelve month high of $70.48. The firm has a market cap of $20,770.80, a price-to-earnings ratio of 15.78, a P/E/G ratio of 1.03 and a beta of 1.51. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.19 and a current ratio of 2.42. Read more …

Week's Most Significant Insider Trades: February 19 - 23, 2018

Disposals:

AFLAC Incorporated (NYSE:AFL) Chairman Daniel P. Amos sold 24,983 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $89.77, for a total transaction of $2,242,723.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Shares of AFLAC Incorporated (AFL) traded down $0.71 on Tuesday, reaching $88.92. 2,280,000 shares of the company traded hands, compared to its average volume of 2,780,000. AFLAC Incorporated has a fifty-two week low of $70.34 and a fifty-two week high of $91.73. The firm has a market capitalization of $34,960.00, a PE ratio of 8.08, a price-to-earnings-growth ratio of 2.34 and a beta of 1.01. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.07 and a quick ratio of 0.07. Read more …

C.H. Robinson Worldwide Inc (NASDAQ:CHRW) insider James Lemke sold 4,346 shares of the company’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $92.75, for a total value of $403,091.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. C.H. Robinson Worldwide Inc (NASDAQ:CHRW) traded down $2.65 during trading hours on Tuesday, hitting $89.97. The stock had a trading volume of 1,204,381 shares, compared to its average volume of 1,810,855. The stock has a market capitalization of $12,820.00, a price-to-earnings ratio of 25.78, a PEG ratio of 2.40 and a beta of 0.46. C.H. Robinson Worldwide Inc has a 52-week low of $63.41 and a 52-week high of $100.18. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.24 and a current ratio of 1.26. Read more …

Tyson Foods, Inc. (NYSE:TSN) Director Gaurdie E. Jr. Banister sold 7,800 shares of the company’s stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $75.56, for a total transaction of $589,368.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Shares of Tyson Foods, Inc. (NYSE:TSN) traded up $0.03 during trading hours on Tuesday, hitting $76.04. 640,657 shares of the company were exchanged, compared to its average volume of 2,213,056. The company has a quick ratio of 0.70, a current ratio of 1.51 and a debt-to-equity ratio of 0.74. The stock has a market cap of $27,830.00, a P/E ratio of 15.34, a P/E/G ratio of 1.03 and a beta of 0.17. Tyson Foods, Inc. has a 52 week low of $57.20 and a 52 week high of $84.65. Read more …

Michael Kors Holdings Ltd (NYSE:KORS) Director M William Benedetto sold 4,000 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $63.94, for a total transaction of $255,760.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Michael Kors Holdings Ltd (NYSE KORS) traded up $0.07 during mid-day trading on Tuesday, hitting $63.97. 3,731,451 shares of the stock traded hands, compared to its average volume of 2,561,981. The stock has a market cap of $9,740.00, a P/E ratio of 18.54, a P/E/G ratio of 2.04 and a beta of 0.08. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.00 and a quick ratio of 1.06. Michael Kors Holdings Ltd has a fifty-two week low of $32.38 and a fifty-two week high of $69.95. Read more …

Notable Analyst Upgrades and Downgrades for Week of January 29, 2018

Upgrades

Allergan (NYSE:AGN) was upgraded by analysts at Barclays from an “equal weight” rating to an “overweight” rating in a report issued on Monday. The brokerage currently has a $230.00 target price on the stock, up from their prior target price of $220.00. Barclays’ target price suggests a potential upside of 24.74% from the company’s current price. The analysts noted that the move was a valuation call. AGN has been the topic of a number of other research reports. Zacks Investment Research lowered shares of Allergan from a “hold” rating to a “sell” rating in a report on Tuesday, January 2nd. Deutsche Bank set a $251.00 target price on shares of Allergan and gave the stock a “buy” rating in a research report on Tuesday, October 17th. TheStreet downgraded shares of Allergan from a “c-” rating to a “d+” rating in a research report on Monday, December 4th. Piper Jaffray Companies set a $227.00 target price on shares of Allergan and gave the stock a “hold” rating in a research report on Friday, October 6th. Finally, JPMorgan Chase & Co. reissued a “buy” rating and issued a $275.00 target price on shares of Allergan in a research report on Monday, October 16th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the company’s stock. Allergan has a consensus rating of “Hold” and a consensus price target of $227.56. Read more …

Kinder Morgan (NYSE:KMI) was upgraded by stock analysts at Argus from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. The analysts noted that the move was a valuation call. Several other equities research analysts also recently weighed in on the company. Royal Bank of Canada restated a “hold” rating and set a $22.00 price target on shares of Kinder Morgan in a report on Wednesday, November 15th. Goldman Sachs Group downgraded Kinder Morgan from a “buy” rating to a “neutral” rating and increased their price objective for the company from $18.81 to $22.00 in a report on Tuesday, October 17th. Stifel Nicolaus dropped their price objective on Kinder Morgan from $25.00 to $22.00 and set a “buy” rating on the stock in a report on Tuesday, October 24th. Bank of America started coverage on Kinder Morgan in a report on Tuesday, January 9th. They issued a “neutral” rating on the stock. Finally, Morgan Stanley dropped their price objective on Kinder Morgan from $25.00 to $24.00 and set an “overweight” rating on the stock in a report on Friday, November 17th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating to the company. Kinder Morgan currently has an average rating of “Hold” and a consensus price target of $22.72. Read more …

Citigroup upgraded shares of Gilead Sciences (NASDAQ:GILD) from a neutral rating to a buy rating in a report released on Tuesday morning. Citigroup currently has $76.00 price target on the biopharmaceutical company’s stock, down from their previous price target of $88.80. Several other analysts have also weighed in on the stock. Vetr lowered shares of Gilead Sciences from a buy rating to a hold rating and set a $91.25 price objective for the company. in a report on Monday. Jefferies Group raised shares of Gilead Sciences from a hold rating to a buy rating and raised their price target for the company from $81.19 to $93.00 in a report on Friday, January 26th. Zacks Investment Research lowered shares of Gilead Sciences from a hold rating to a sell rating in a report on Thursday, January 18th. BidaskClub raised shares of Gilead Sciences from a sell rating to a hold rating in a report on Tuesday, January 16th. Finally, Wells Fargo & Co raised shares of Gilead Sciences from a market perform rating to an outperform rating and raised their price target for the company from $79.02 to $96.00 in a report on Tuesday, January 16th. One analyst has rated the stock with a sell rating, thirteen have given a hold rating and eighteen have issued a buy rating to the stock. Gilead Sciences currently has an average rating of Buy and a consensus target price of $85.58. Read more …

Foot Locker (NYSE:FL) was upgraded by stock analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a research note issued to investors on Wednesday. Several other research firms also recently issued reports on FL. Cowen set a $40.00 price objective on Foot Locker and gave the company a “hold” rating in a report on Saturday, November 18th. Zacks Investment Research upgraded Foot Locker from a “sell” rating to a “hold” rating in a report on Monday, October 23rd. Deutsche Bank upgraded Foot Locker from a “hold” rating to a “buy” rating and boosted their price objective for the company from $38.00 to $45.00 in a report on Friday, November 17th. Wells Fargo & Co set a $42.00 price objective on Foot Locker and gave the company a “hold” rating in a report on Monday, November 20th. Finally, Pivotal Research initiated coverage on Foot Locker in a report on Thursday, January 25th. They issued a “buy” rating and a $65.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and fifteen have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $56.04. Read more …

This Week's Most Significant Insider Trades: December 4 - 8, 2017

Disposals:

Apple Inc. (NASDAQ:AAPL) insider Eduardo H. Cue sold 65,361 shares of the firm’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $171.60, for a total value of $11,215,947.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.  Shares of Apple Inc. (AAPL) opened at $169.01 on Thursday. The firm has a market cap of $871,806.19, a P/E ratio of 18.46, a price-to-earnings-growth ratio of 1.36 and a beta of 1.22. Apple Inc. has a one year low of $109.16 and a one year high of $176.24. The company has a quick ratio of 1.23, a current ratio of 1.28 and a debt-to-equity ratio of 0.73. Read more...

C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) VP Ben G. Campbell sold 4,865 shares of the business’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $85.00, for a total transaction of $413,525.00. Following the completion of the sale, the vice president now owns 29,837 shares in the company, valued at approximately $2,536,145. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) opened at $87.15 on Thursday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.24 and a quick ratio of 1.24. The company has a market cap of $11,977.70, a PE ratio of 25.65, a price-to-earnings-growth ratio of 2.95 and a beta of 0.48. C.H. Robinson Worldwide, Inc. has a one year low of $63.41 and a one year high of $89.11. Read more ... 

Costco Wholesale Co. (NASDAQ:COST) Director John W. Meisenbach sold 3,000 shares of the stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $183.26, for a total transaction of $549,780.00. Following the sale, the director now directly owns 8,654 shares of the company’s stock, valued at approximately $1,585,932.04. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Costco Wholesale Co. (NASDAQ:COST) opened at $187.22 on Thursday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.43 and a current ratio of 0.99. Costco Wholesale Co. has a 52 week low of $150.00 and a 52 week high of $191.22. The firm has a market capitalization of $82,075.39, a price-to-earnings ratio of 32.27, a price-to-earnings-growth ratio of 3.05 and a beta of 0.98. Read more ...

Exxon Mobil Corporation (NYSE:XOM) VP Robert N. Schleckser sold 4,877 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $83.37, for a total value of $406,595.49. Following the completion of the transaction, the vice president now directly owns 187,663 shares of the company’s stock, valued at $15,645,464.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Read more ...

Insider James M. Spellings, Jr. sold 9,379 shares of the firm’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $83.37, for a total value of $781,927.23. Following the completion of the transaction, the insider now directly owns 220,000 shares of the company’s stock, valued at $18,341,400. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Read more ...

Franklin Resources, Inc. (NYSE:BEN) Vice Chairman Rupert H. Johnson, Jr. sold 400,000 shares of the stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $42.95, for a total value of $17,180,000.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Shares of Franklin Resources, Inc. (NYSE BEN) traded up $0.13 during trading on Monday, hitting $43.48. The stock had a trading volume of 2,921,800 shares, compared to its average volume of 2,250,454. The company has a debt-to-equity ratio of 0.08, a current ratio of 8.75 and a quick ratio of 8.75. The company has a market cap of $24,620.00, a price-to-earnings ratio of 14.49, a PEG ratio of 1.49 and a beta of 1.75. Franklin Resources, Inc. has a 12-month low of $38.93 and a 12-month high of $47.65. Read more ...

Rockwell Automation, Inc. (NYSE:ROK) CEO Blake D. Moret sold 5,309 shares of the business’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $190.75, for a total value of $1,012,691.75. Following the completion of the sale, the chief executive officer now owns 30,720 shares in the company, valued at $5,859,840. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Read more ...

Eli Lilly and Company (NYSE:LLY) SVP Susan Mahony sold 36,585 shares of the business’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $86.18, for a total transaction of $3,152,895.30. Following the transaction, the senior vice president now directly owns 54,885 shares in the company, valued at $4,729,989.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Shares of Eli Lilly and Company (NYSE:LLY) traded up $0.48 during trading hours on Tuesday, hitting $86.06. The stock had a trading volume of 3,876,686 shares, compared to its average volume of 3,672,667. Eli Lilly and Company has a 52 week low of $66.39 and a 52 week high of $89.09. The firm has a market capitalization of $93,945.43, a price-to-earnings ratio of 20.86, a PEG ratio of 1.87 and a beta of 0.35. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.03 and a current ratio of 1.38. Read more ...

Ecolab Inc. (NYSE:ECL) CEO Douglas M. Baker, Jr. sold 18,000 shares of Ecolab stock in a transaction dated Wednesday, December 6th. The stock was sold at an average price of $137.09, for a total transaction of $2,467,620.00. Following the transaction, the chief executive officer now directly owns 427,548 shares of the company’s stock, valued at $58,612,555.32. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Read more ...

Ecolab Inc. (NYSE:ECL) insider Thomas W. Handley sold 11,644 shares of the business’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $137.50, for a total value of $1,601,050.00. Following the completion of the sale, the insider now directly owns 109,542 shares of the company’s stock, valued at approximately $15,062,025. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Read more ...

Ecolab Inc. (NYSE:ECL) EVP Michael A. Hickey sold 19,300 shares of the firm’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $137.54, for a total value of $2,654,522.00. Following the sale, the executive vice president now directly owns 43,262 shares in the company, valued at approximately $5,950,255.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Read more ...

Halliburton Company (NYSE:HAL) insider James S. Brown sold 29,485 shares of the company’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $44.01, for a total transaction of $1,297,634.85. Following the sale, the insider now directly owns 129,646 shares of the company’s stock, valued at $5,705,720.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Halliburton Company (NYSE:HAL) traded down $0.26 during mid-day trading on Wednesday, reaching $43.63. 8,993,000 shares of the company’s stock traded hands, compared to its average volume of 8,786,670. Halliburton Company has a fifty-two week low of $38.18 and a fifty-two week high of $58.78. The company has a quick ratio of 1.67, a current ratio of 2.20 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $38,295.82, a price-to-earnings ratio of 60.12, a P/E/G ratio of 4.74 and a beta of 1.03. Read more ...

Microsoft Corporation (NASDAQ:MSFT) insider Frank H. Brod sold 18,000 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $83.15, for a total transaction of $1,496,700.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Microsoft Corporation (NASDAQ:MSFT) traded up $1.19 during trading on Wednesday, hitting $82.78. The stock had a trading volume of 26,047,869 shares, compared to its average volume of 22,490,900. Microsoft Corporation has a twelve month low of $59.80 and a twelve month high of $86.20. The company has a debt-to-equity ratio of 0.91, a current ratio of 3.12 and a quick ratio of 3.06. The stock has a market capitalization of $625,499.00, a PE ratio of 23.99, a PEG ratio of 1.89 and a beta of 0.99. Read more ...

Acquisitions:

Prospect Capital Corporation (NASDAQ:PSEC) CEO John F. Barry bought 170,460 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was acquired at an average price of $6.86 per share, for a total transaction of $1,169,355.60. Following the completion of the acquisition, the chief executive officer now directly owns 27,031,950 shares in the company, valued at $185,439,177. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Prospect Capital Corporation (NASDAQ:PSEC) traded down $0.06 during midday trading on Monday, hitting $6.73. 3,001,600 shares of the company were exchanged, compared to its average volume of 2,854,813. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.63 and a quick ratio of 2.63. Prospect Capital Corporation has a twelve month low of $5.51 and a twelve month high of $9.58. The company has a market cap of $2,430.00, a P/E ratio of 8.38 and a beta of 0.55. Read more ...

Allergan PLC. (NYSE:AGN) Director Christopher J. Coughlin bought 10,000 shares of the firm’s stock in a transaction dated Tuesday, December 5th. The shares were acquired at an average price of $163.30 per share, with a total value of $1,633,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Allergan PLC. (NYSE AGN) opened at $164.87 on Friday. Allergan PLC. has a 52 week low of $160.07 and a 52 week high of $256.80. The company has a quick ratio of 1.08, a current ratio of 1.18 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $54,636.75, a PE ratio of 10.65, a price-to-earnings-growth ratio of 1.10 and a beta of 1.11. Read more ...

Allergan PLC. (NYSE:AGN) Chairman Brent L. Saunders purchased 4,600 shares of the stock in a transaction that occurred on Wednesday, December 6th. The shares were purchased at an average price of $164.74 per share, with a total value of $757,804.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Read more ...

Allergan PLC. (NYSE:AGN) Director Chris W. Bodine acquired 3,030 shares of Allergan stock in a transaction dated Thursday, December 7th. The shares were acquired at an average price of $164.77 per share, with a total value of $499,253.10. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Read more ...

Kimco Realty Corporation (NYSE:KIM) insider Milton Cooper acquired 50,000 shares of the business’s stock in a transaction on Monday, December 4th. The stock was bought at an average cost of $19.20 per share, for a total transaction of $960,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Shares of Kimco Realty Corporation (NYSE KIM) traded down $0.61 during mid-day trading on Tuesday, reaching $18.48. The company’s stock had a trading volume of 4,565,286 shares, compared to its average volume of 4,425,415. The company has a debt-to-equity ratio of 0.16, a quick ratio of 0.08 and a current ratio of 0.08. Kimco Realty Corporation has a 12 month low of $17.02 and a 12 month high of $26.63. The firm has a market capitalization of $7,874.59, a P/E ratio of 12.25, a P/E/G ratio of 2.15 and a beta of 0.65. Read more ...

CenturyLink, Inc. (NYSE:CTL) COO Jeffrey K. Storey bought 71,000 shares of the stock in a transaction on Friday, December 8th. The stock was purchased at an average price of $14.30 per share, for a total transaction of $1,015,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Read more ...

CenturyLink, Inc. (NYSE:CTL) CEO Glen F. Post III bought 50,000 shares of the stock in a transaction on Friday, December 8th. The shares were purchased at an average price of $14.17 per share, with a total value of $708,500.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Read more ...

CenturyLink, Inc. (NYSE:CTL) Vice Chairman William Bruce Hanks purchased 10,000 shares of the company’s stock in a transaction dated Friday, December 8th. The stock was bought at an average cost of $14.41 per share, for a total transaction of $144,100.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. CenturyLink, Inc. (NYSE CTL) traded up $0.57 during trading hours on Friday, hitting $14.67. The stock had a trading volume of 15,064,300 shares, compared to its average volume of 10,852,934. The company has a debt-to-equity ratio of 1.92, a current ratio of 0.82 and a quick ratio of 0.82. The stock has a market cap of $14,795.00, a price-to-earnings ratio of 7.13, a price-to-earnings-growth ratio of -4.33 and a beta of 0.79. CenturyLink, Inc. has a 52-week low of $13.16 and a 52-week high of $27.61. Read more ...

In case you interested of stock analysis of other bloggers, click on link below:

Analysis Collection

Notable Analyst Upgrades and Downgrades for Week of Nov 27 - Dec 1, 2017

Upgrades:

National Grid plc (LON:NG) was upgraded by investment analysts at Credit Suisse Group to a “neutral” rating in a research note issued to investors on Monday. The firm presently has a GBX 860 ($11.31) price target on the stock. Credit Suisse Group’s price target would indicate a potential downside of 0.76% from the stock’s previous close. Several other equities analysts have also recently commented on NG. Deutsche Bank AG reduced their target price on National Grid from GBX 950 ($12.50) to GBX 900 ($11.84) and set a “sell” rating for the company in a research report on Thursday, August 17th. J P Morgan Chase & Co restated an “overweight” rating and set a GBX 1,060 ($13.94) target price on shares of National Grid in a research report on Thursday, November 16th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 1,050 ($13.81) price target on shares of National Grid in a research note on Tuesday, August 1st. Read more …

Allergan (NYSE:AGN) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a note issued to investors on Wednesday. AGN has been the subject of several other research reports. Citigroup restated a “buy” rating and issued a $280.00 target price on shares of Allergan in a research note on Wednesday, September 20th. Deutsche Bank set a $251.00 target price on Allergan and gave the stock a “buy” rating in a research note on Tuesday, October 17th. Piper Jaffray Companies set a $227.00 target price on Allergan and gave the stock a “hold” rating in a research note on Friday, October 6th. J P Morgan Chase & Co restated a “buy” rating and issued a $275.00 target price on shares of Allergan in a research note on Monday, October 16th. Read more …

Wal-Mart Stores (NYSE:WMT) was upgraded by research analysts at Royal Bank Of Canada from an “underperform” rating to a “sector perform” rating in a report issued on Wednesday, Marketbeat reports. The brokerage currently has a $96.00 target price on the retailer’s stock. Royal Bank Of Canada’s price target points to a potential downside of 1.60% from the company’s current price. Several other analysts have also issued reports on the stock. Vetr upgraded shares of Wal-Mart Stores from a “sell” rating to a “hold” rating and set a $96.71 target price on the stock in a research report on Monday. Cowen reiterated a “buy” rating and issued a $110.00 target price on shares of Wal-Mart Stores in a research report on Wednesday, November 22nd. Read more …

Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded by stock analysts at TD Securities to a “buy” rating in a note issued to investors on Thursday, The Fly reports. The analysts noted that the move was a valuation call. Other analysts have also recently issued research reports about the stock. Goldman Sachs Group started coverage on shares of Canadian National Railway in a research note on Monday, November 13th. They set a “buy” rating and a $85.00 target price on the stock. Desjardins raised shares of Canadian National Railway from a “hold” rating to a “buy” rating in a research note on Wednesday, October 25th. Cowen reaffirmed a “buy” rating and set a $83.00 target price on shares of Canadian National Railway in a research note on Sunday, September 24th. Stifel Nicolaus reaffirmed a “hold” rating and set a $89.00 target price on shares of Canadian National Railway in a research note on Friday, October 6th. Read more …

Canadian Imperial Bank of Commerce (NYSE:CM) (TSE:CM) was upgraded by equities researchers at Credit Suisse Group from a “neutral” rating to an “outperform” rating in a report released on Friday, MarketBeat Ratings reports. The firm presently has a $125.00 target price on the bank’s stock, up from their prior target price of $116.00. Credit Suisse Group’s target price indicates a potential upside of 30.93% from the company’s previous close. Other analysts have also recently issued research reports about the company. TD Securities raised Canadian Imperial Bank of Commerce from a “hold” rating to a “buy” rating and set a $120.00 target price for the company in a research report on Wednesday, September 6th. Canaccord Genuity set a $117.00 target price on Canadian Imperial Bank of Commerce and gave the stock a “buy” rating in a research report on Thursday, August 24th. Read more …

Novo Nordisk A/S (NYSE:NVO) was upgraded by equities research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report released on Friday, MarketBeat Ratings reports. Other analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of Novo Nordisk A/S from a “hold” rating to a “buy” rating and set a $55.00 price target on the stock in a report on Tuesday, October 10th. BidaskClub upgraded shares of Novo Nordisk A/S from a “sell” rating to a “hold” rating in a report on Saturday, August 12th. BNP Paribas cut shares of Novo Nordisk A/S from an “outperform” rating to a “neutral” rating in a report on Monday, September 25th. Read more …

Downgrades:

Robert W. Baird downgraded shares of Kimco Realty Corporation (NYSE:KIM) from an outperform rating to a neutral rating in a research report released on Monday morning. The firm currently has $20.00 price objective on the real estate investment trust’s stock, down from their previous price objective of $23.00. A number of other research analysts also recently weighed in on KIM. BidaskClub upgraded shares of Kimco Realty from a hold rating to a buy rating in a research report on Thursday, August 10th. Citigroup Inc. upped their price objective on shares of Kimco Realty from $19.50 to $21.00 and gave the stock a neutral rating in a research report on Monday, August 14th. Boenning Scattergood reiterated a hold rating on shares of Kimco Realty in a research report on Friday, August 18th. J P Morgan Chase & Co upgraded shares of Kimco Realty from a neutral rating to an overweight rating and set a $24.00 price objective for the company in a research report on Tuesday, September 26th. Read more …

Nike (NYSE:NKE) was downgraded by equities researchers at HSBC from a “buy” rating to a “hold” rating in a research note issued on Tuesday, MarketBeat reports. They presently have a $62.00 price target on the footwear maker’s stock, up from their previous price target of $58.95. HSBC’s target price would suggest a potential upside of 3.97% from the stock’s previous close. Several other equities analysts have also recently weighed in on the company. Robert W. Baird restated a “buy” rating and set a $65.00 price objective on shares of Nike in a research note on Friday, November 17th. Vetr cut Nike from a “buy” rating to a “hold” rating and set a $58.81 price objective on the stock. in a research note on Friday, November 17th. B. Riley restated a “neutral” rating on shares of Nike in a research note on Wednesday, November 1st. Read more …

QUALCOMM (NASDAQ:QCOM) was downgraded by stock analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a report issued on Tuesday, The Fly reports. Other research analysts also recently issued reports about the company. BMO Capital Markets restated a “market perform” rating and set a $55.00 price objective on shares of QUALCOMM in a research note on Thursday, August 24th. William Blair restated a “market perform” rating on shares of QUALCOMM in a research note on Tuesday, September 5th. Wells Fargo & Company restated an “outperform” rating on shares of QUALCOMM in a research note on Monday, July 31st. Zacks Investment Research upgraded QUALCOMM from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Read more …

Colgate-Palmolive (NYSE:CL) was downgraded by Societe Generale from a “hold” rating to a “sell” rating in a report released on Wednesday, MarketBeat Ratings reports. They presently have a $66.00 target price on the stock. Societe Generale’s price target would indicate a potential downside of 8.35% from the company’s current price. The analysts noted that the move was a valuation call. Several other equities research analysts also recently commented on the stock. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Monday, October 23rd. Morgan Stanley upgraded shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $75.00 to $84.00 in a research note on Monday, September 25th. Read more …

William Blair lowered shares of Chipotle Mexican Grill (NYSE:CMG) from an outperform rating to a market perform rating in a research report report published on Wednesday. CMG has been the topic of several other reports. Piper Jaffray Companies set a $510.00 price target on shares of Chipotle Mexican Grill and gave the stock a buy rating in a report on Wednesday, October 11th. Jefferies Group cut their price target on shares of Chipotle Mexican Grill to $300.00 and set a positive rating on the stock in a report on Wednesday, October 25th. Robert W. Baird restated a hold rating and set a $385.00 price target on shares of Chipotle Mexican Grill in a report on Friday, September 1st. Deutsche Bank restated a sell rating and set a $250.00 price target (down from $315.00) on shares of Chipotle Mexican Grill in a report on Tuesday, August 22nd. Read more …

Cummins (NYSE:CMI) was downgraded by research analysts at Goldman Sachs Group from a “buy” rating to a “neutral” rating in a research report issued on Thursday, The Fly reports. A number of other brokerages have also recently issued reports on CMI. Stifel Nicolaus reiterated a “hold” rating and set a $190.00 target price (up previously from $186.00) on shares of Cummins in a research report on Wednesday, November 1st. Buckingham Research started coverage on shares of Cummins in a research report on Tuesday, September 5th. They issued a “buy” rating and a $180.00 price objective for the company. Piper Jaffray Companies restated a “hold” rating and issued a $159.00 price objective on shares of Cummins in a research report on Thursday, August 3rd. Read more …

Citigroup downgraded shares of GAP (NYSE:GPS) from a neutral rating to a sell rating in a research report report published on Thursday. Citigroup currently has $25.00 target price on the apparel retailer’s stock, down from their previous target price of $32.50. A number of other equities analysts have also recently issued reports on the stock. ValuEngine raised shares of GAP from a buy rating to a strong-buy rating in a report on Thursday. Cowen reissued a hold rating and issued a $32.00 target price on shares of GAP in a report on Wednesday, November 22nd. Zacks Investment Research raised shares of GAP from a sell rating to a hold rating in a report on Monday, November 20th. KeyCorp set a $35.00 target price on shares of GAP and gave the stock a buy rating in a report on Thursday, November 16th. Read more …

Sanofi (NYSE:SNY) was downgraded by stock analysts at Morgan Stanley from an “overweight” rating to an “underweight” rating in a report released on Friday. Several other equities research analysts have also issued reports on the stock. Argus restated a “buy” rating and issued a $55.00 target price on shares of Sanofi in a report on Friday, September 1st. Zacks Investment Research lowered shares of Sanofi from a “hold” rating to a “strong sell” rating in a report on Friday, October 6th. raised shares of Sanofi from a “reduce” rating to a “hold” rating in a report on Wednesday, August 30th. Barclays raised shares of Sanofi from an “underweight” rating to an “equal weight” rating in a research report on Wednesday, November 15th. Read more …

In case you interested of stock analysis of other bloggers, click on link below:

Analysis Collection